CD14 and rheumatoid arthritis: In fact, the proportion of CD14+CD16+ intermediate monocytes is increased in RA synovial fluid [29] and at peripheral level [27,29,33,34]; it is also correlated to disease activity [33], and predicts the response to methotrexate therapy [23,35].